Study participants lost an average of 12.4 per cent of their body weight over 72 weeks. View on euronews ...

Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...

Eli Lilly, a renowned drug manufacturer, stated that its GLP-1 pill, orforglipron, assisted individuals in reducing 12.4% of their weight following 72 weeks in a late-stage study.The company ...

High demand expected for new daily weight loss pill - The tablet could be a cheaper and more convenient alternative to ...